• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ambit Biosciences Corp

AMBI:US

Acquired

Ambit Biosciences Corp (AMBI:US) was acquired by 4568:JP


Company Profile

Ambit Biosciences Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule and orally administered enzyme inhibitors for the treatment of acute myeloid leukemia and inflammatory diseases. Ambit Biosciences operates in the United States.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
Advertisement
sec ||= nil